Metabolic Syndrome
Researchers from the United States and Canada N6A 5K8 report details of new studies and findings in the area of metabolic syndrome
Published in Obesity and Diabetes Week, June 19th, 2006
Study 1: PPARdelta is a potential target of the metabolic syndrome.
According to a recent review from the United States, "Obesity is a growing threat to global health by virtue of its association with insulin resistance, glucose intolerance, hypertension, and dyslipidemia, collectively known as the metabolic syndrome or syndrome X. The nuclear receptors PPARalpha and PPARgamma are therapeutic targets for hypertriglyceridemia and insulin resistance, respectively, and drugs that modulate these receptors are currently in clinical use."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Epidemiology
Maintenance of leanness in adolescences and adulthood can prevent type 2 diabetes - Diabetes Therapy
Etanercept reduces C-reactive protein levels in patients with the metabolic syndrome - Diet & Nutrition
N-3 Fatty acids modulate antioxidant status in diabetic rats and macrosomic offspring - Obesity Pathogenesis
Lipid metabolism and adipokine levels are altered in fatty acid-binding protein null mice - Obesity Pathogenesis
LKB1-AMPK signaling in muscle from obese insulin-resistant rats can be restored by training - Arthritis
Risk factors for lack of recent exercise in adults with arthritis are assessed - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
